Skip to main content
. 2023 Apr 25;2023(4):CD013871. doi: 10.1002/14651858.CD013871.pub2

1.6. Analysis.

1.6

Comparison 1: Fecal microbiota transplantation (FMT) versus control for the treatment of recurrent Clostridioides difficile infections (rCDI), Outcome 6: Serious adverse events: sensitivity analysis: fixed‐effect model